Autolus Therapeutics Plc (AUTL)
2.24
-0.07
(-3.03%)
USD |
NASDAQ |
Sep 02, 16:00
2.23
-0.01
(-0.45%)
After-Hours: 18:50
Autolus Therapeutics Research and Development Expense (TTM) : 112.42M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 112.42M |
| March 31, 2026 | 112.24M |
| December 31, 2025 | 117.80M |
| September 30, 2025 | 112.77M |
| June 30, 2025 | 125.37M |
| March 31, 2025 | 134.21M |
| December 31, 2024 | 138.15M |
| September 30, 2024 | 132.76M |
| June 30, 2024 | 124.57M |
| March 31, 2024 | 121.31M |
| December 31, 2023 | 118.27M |
| September 30, 2023 | 120.03M |
| June 30, 2023 | 125.53M |
| March 31, 2023 | 130.39M |
| Date | Value |
|---|---|
| December 31, 2022 | 136.72M |
| September 30, 2022 | 149.44M |
| June 30, 2022 | 144.10M |
| March 31, 2022 | 138.02M |
| December 31, 2021 | 134.79M |
| September 30, 2021 | 133.88M |
| June 30, 2021 | 135.14M |
| March 31, 2021 | 134.33M |
| December 31, 2020 | 134.89M |
| September 30, 2020 | 125.53M |
| June 30, 2020 | 119.29M |
| March 31, 2020 | 114.14M |
| December 31, 2019 | 105.42M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Bicycle Therapeutics Plc | 226.38M |
| Biodexa Pharmaceuticals Plc | 5.234M |
| argenx SE | 1.640B |
| NuCana Plc | 12.59M |
| Mereo BioPharma Group Plc | 14.98M |